Pfizer to supply U.S. with 10 mln more courses of COVID-19 pills
The Biden administration doubled its order for Pfizer Inc's oral COVID-19 antiviral treatment, the company and the White House said on Tuesday, providing the government a total of 20 million courses as it fights a record surge https://www.reuters.com/world/us/us-reports-nearly-1-mln-covid-19-cases-day-setting-global-record-2022-01-04 in COVID-19 cases.
The Biden administration doubled its order for Pfizer Inc's oral COVID-19 antiviral treatment, the company and the White House said on Tuesday, providing the government a total of 20 million courses as it fights a record surge https://www.reuters.com/world/us/us-reports-nearly-1-mln-covid-19-cases-day-setting-global-record-2022-01-04 in COVID-19 cases. The White House now expects some 4 million treatment courses of the pills to be available by the end of January and 10 million by June, three months sooner than previously planned, according to an administration official.
"We're getting them as soon as they come off the line," the official said. Details of the expanded deal, Pfizer's largest yet for the pill, were not disclosed by the company.
For the first order of 10 million courses in November, the U.S. government had said it would pay Pfizer $5.29 billion. "These pills will be delivered in the coming months and have been shown to dramatically decrease hospitalization and death from COVID-19," the White House said on Twitter.
Pfizer's two-drug regimen called Paxlovid, which is meant to be taken at home for five days soon after onset of COVID symptoms, was authorized last month for people aged 12 and older. In a clinical trial, it was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness. The U.S. official said Washington could activate the Defense Production Act or use other extraordinary powers to speed deliveries if Pfizer encounters any production difficulties.
A rival antiviral pill from Merck & Co also won regulatory authorization last month. The U.S. government has a deal for as many as 5 million courses of the pill, molnupiravir, at a price of $700 per course. (Editing by Shinjini Ganguli and Bill Berkrot)
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- COVID
- U.S.
- Biden
- Defense
- Merck & Co
- Bill Berkrot
- The White House
- White House
- Washington
- Pfizer
- Paxlovid
ALSO READ
Paul Simon to play for Japan's Kishida, Bidens at White House state dinner
Biden and Japanese PM unite for stronger alliance during White House visit
Biden and First Lady Extend Warm Welcome to Japanese PM and his Wife at the White House
White House: US condemns Ecuador's armed raid of Mexico's embassy
US asked Ecuador to work with Mexico to find resolution after diplomatic dispute, White House says